The requirements for research, clinical evidence and marketing authorisation of medical devices are continuously increasing. Nowadays, it takes up to 10 years to develop and authorise a new device, plus another 5 years until an innovation is mapped in the SwissDRG system for fixed rate per case payments in hospitals and reimbursed by compulsory health insurance (OKP). In the interest of speedy patient access to the latest examination and treatment methods, quick replacement of existing technologies with potentially cost-saving, better quality methods, and to protect the innovativeness of Swiss healthcare and strengthen Switzerland as a place for development, research and production, it is essential to rectify this process inefficiency.